Ftse Mib
38.348,16
-0,53%
DAX
22.433,63
-1,88%
S&P 500
6.144,15
0,24%
NASDAQ
20.056,25
0,07%
Bitcoin
96.900,29
0,28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Genmab AS (GE9) Genmab AS (GE9) Notizie

Genmab AS

GE9
210,90
0,20 (0,09%)
19 Feb 2025 - Chiuso
Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
19/2/202515:14UKREGGenmab to Participate in a Fireside Chat at the 45th Annual..
13/2/202512:00UKREGNotice to Convene the Annual General Meeting of Genmab A/S
12/2/202519:14UKREGGenmab Files Annual Report with the U.S. Securities and..
12/2/202517:01UKREGGenmab Publishes 2024 Annual Report
23/1/202521:08UKREGGrant of Restricted Stock Units and Warrants to Employees in..
22/1/202512:23UKREGGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
03/1/202519:55UKREGGenmab to Present at the 43rd Annual J.P. Morgan Healthcare..
11/12/202414:20UKREGGenmab to Hold 2024 R&D Update and ASH Data Review Meeting
09/12/202418:00UKREGTwo Data Analyses from Clinical Trials Show Epcoritamab..
08/12/202417:00UKREGInvestigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy..
08/12/202401:12UKREGInvestigational Epcoritamab (DuoBody® CD3xCD20) Combination..
03/12/202422:35UKREGCapital Increase in Genmab as a Result of Employee Warrant..
03/12/202413:07UKREGTransactions With Shares and Linked Securities in Genmab A/S..
25/11/202417:05UKREGGenmab to Present at Citi’s Global Healthcare Conference
21/11/202420:47UKREGGrant of Restricted Stock Units and Warrants to Employees in..
06/11/202417:01UKREGGenmab Announces Financial Results for the First Nine Months..
05/11/202419:10UKREGGenmab to Present at Jefferies London Healthcare Conference
05/11/202418:00UKREGGenmab to Showcase Strength and Breadth of Comprehensive..
15/10/202412:25UKREGGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
04/10/202419:55UKREGMajor Shareholder Announcement
26/9/202421:17UKREGGrant of Restricted Stock Units and Warrants to Employees in..
15/9/202414:45UKREGInvestigational Rinatabart Sesutecan (Rina-S) Shows..
10/9/202422:06UKREGCapital Increase in Genmab as a Result of Employee Warrant..
26/8/202418:26UKREGGenmab to Present at Morgan Stanley 22nd Annual Global..
19/8/202420:00UKREGTEPKINLY® (epcoritamab) Receives Second European Commission..
16/8/202415:00UKREGGenmab Announces Changes to its Executive Committee
13/8/202420:53UKREGTransactions with shares and linked securities in Genmab A/S..
13/8/202420:50UKREGCapital Increase in Genmab as a Result of Employee Warrant..
08/8/202417:03UKREGGenmab Announces Financial Results for the First Half of..
08/8/202417:00UKREGGenmab Updates 2024 Financial Guidance
05/8/202411:50UKREGGenmab Takes Full Control of Acasunlimab Development Program
17/7/202412:25UKREGGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
28/6/202408:00GLOBEEpcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for..
27/6/202423:00GLOBECompletion of Share Buy-back Program
27/6/202401:03GLOBEEPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for..
24/6/202415:55GLOBETransactions in Connection with Share Buy-back Program
18/6/202420:45GLOBECapital Increase in Genmab as a Result of Employee Warrant..
17/6/202415:33GLOBETransactions in Connection with Share Buy-back Program
12/6/202421:45GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
11/6/202420:50GLOBETransactions with shares and linked securities in Genmab A/S..
10/6/202416:18GLOBETransactions in Connection with Share Buy-back Program
05/6/202418:51GLOBEGenmab to Participate in a Fireside Chat at the Goldman..
03/6/202415:09GLOBETransactions in Connection with Share Buy-back Program
03/6/202415:00GLOBEInvestigational Tisotumab Vedotin Phase 2 Data Demonstrates..
02/6/202423:30GLOBEPreliminary Analysis of Data Evaluating Investigational..
01/6/202416:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in..
27/5/202416:16GLOBETransactions in Connection with Share Buy-back Program
23/5/202423:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
21/5/202417:06GLOBEGenmab Completes Acquisition of ProfoundBio
21/5/202413:19GLOBETransactions in Connection with Share Buy-back Program
Apertura: 211,30 Min: 205,00 Max: 212,10
Chiusura: 210,70

La tua Cronologia

TG
GE9
Genmab AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci